Juventas Cell Therapy Ltd.
Clinical trials sponsored by Juventas Cell Therapy Ltd., explained in plain language.
-
Experimental cell therapy targets hard-to-treat blood disorder
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy (Inaticabtagene Autoleucel) for people with autoimmune hemolytic anemia that hasn't improved after at least three other treatments. The study will enroll 12 adults aged 18-75 to check if the treatment is safe and tolerable. The goal…
Phase: PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New cell shot aims to tame stubborn nerve attacks
Disease control Not yet recruitingThis early-phase trial tests a new cell treatment (HY001N) for people with autoimmune neurological diseases that have not responded to standard therapies. The study will enroll 15 adults to check if the treatment is safe and shows any signs of helping control the disease. The goa…
Phase: EARLY_PHASE1 • Sponsor: Juventas Cell Therapy Ltd. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC